Literature DB >> 10405439

Severe end of Opitz trigonocephaly (C) syndrome or new syndrome?

A Bohring1, M Silengo, M Lerone, D W Superneau, C Spaich, S R Braddock, A Poss, J M Opitz.   

Abstract

We report on four unrelated cases of an Opitz trigonocephaly (C)-like syndrome with a highly characteristic combination of facial anomalies including prominent metopic suture, exophthalmos, hypertelorism, cleft lip and palate, flexion deformities of the upper limbs and multiple other anomalies. We also review two very similar published cases formerly considered to have the C syndrome. Although there is overlap, a clinical distinction from the Opitz trigonocephaly and other syndromes seems possible, and thus a specific causal entity may be postulated. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10405439     DOI: 10.1002/(sici)1096-8628(19990827)85:5<438::aid-ajmg2>3.0.co;2-a

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

1.  Exploring by whole exome sequencing patients with initial diagnosis of Rubinstein-Taybi syndrome: the interconnections of epigenetic machinery disorders.

Authors:  Gloria Negri; Pamela Magini; Donatella Milani; Milena Crippa; Elisa Biamino; Maria Piccione; Stefano Sotgiu; Chiara Perrìa; Giuseppina Vitiello; Marina Frontali; Antonella Boni; Elisabetta Di Fede; Maria Chiara Gandini; Elisa Adele Colombo; Michael J Bamshad; Deborah A Nickerson; Joshua D Smith; Italia Loddo; Palma Finelli; Marco Seri; Tommaso Pippucci; Lidia Larizza; Cristina Gervasini
Journal:  Hum Genet       Date:  2019-02-26       Impact factor: 4.132

2.  Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance.

Authors:  Bianca Russell; Jennifer J Johnston; Leslie G Biesecker; Nancy Kramer; Angela Pickart; William Rhead; Wen-Hann Tan; Catherine A Brownstein; L Kate Clarkson; Amy Dobson; Avi Z Rosenberg; Samantha A Schrier Vergano; Benjamin M Helm; Rachel E Harrison; John M Graham
Journal:  Am J Med Genet A       Date:  2015-04-29       Impact factor: 2.802

Review 3.  Bohring-Opitz (Oberklaid-Danks) syndrome: clinical study, review of the literature, and discussion of possible pathogenesis.

Authors:  Rob Hastings; Jan-Maarten Cobben; Gabriele Gillessen-Kaesbach; Judith Goodship; Hanne Hove; Susanne Kjaergaard; Helena Kemp; Helen Kingston; Peter Lunt; Sahar Mansour; Ruth McGowan; Kay Metcalfe; Catherine Murdoch-Davis; Mary Ray; Marlène Rio; Sarah Smithson; John Tolmie; Peter Turnpenny; Bregje van Bon; Dagmar Wieczorek; Ruth Newbury-Ecob
Journal:  Eur J Hum Genet       Date:  2011-02-02       Impact factor: 4.246

4.  Bainbridge-Ropers syndrome caused by loss-of-function variants in ASXL3: a recognizable condition.

Authors:  Alma Kuechler; Johanna Christina Czeschik; Elisabeth Graf; Ute Grasshoff; Ulrike Hüffmeier; Tiffany Busa; Stefanie Beck-Woedl; Laurence Faivre; Jean-Baptiste Rivière; Ingrid Bader; Johannes Koch; André Reis; Ute Hehr; Olaf Rittinger; Wolfgang Sperl; Tobias B Haack; Thomas Wieland; Hartmut Engels; Holger Prokisch; Tim M Strom; Hermann-Josef Lüdecke; Dagmar Wieczorek
Journal:  Eur J Hum Genet       Date:  2016-11-30       Impact factor: 4.246

5.  De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.

Authors:  Vandana Shashi; Loren D M Pena; Katherine Kim; Barbara Burton; Maja Hempel; Kelly Schoch; Magdalena Walkiewicz; Heather M McLaughlin; Megan Cho; Nicholas Stong; Scott E Hickey; Christine M Shuss; Michael S Freemark; Jane S Bellet; Martha Ann Keels; Melanie J Bonner; Maysantoine El-Dairi; Megan Butler; Peter G Kranz; Constance T R M Stumpel; Sylvia Klinkenberg; Karin Oberndorff; Malik Alawi; Rene Santer; Slavé Petrovski; Outi Kuismin; Satu Korpi-Heikkilä; Olli Pietilainen; Palotie Aarno; Mitja I Kurki; Alexander Hoischen; Anna C Need; David B Goldstein; Fanny Kortüm
Journal:  Am J Hum Genet       Date:  2016-09-29       Impact factor: 11.025

Review 6.  Surveillance Recommendations for Children with Overgrowth Syndromes and Predisposition to Wilms Tumors and Hepatoblastoma.

Authors:  Jennifer M Kalish; Leslie Doros; Lee J Helman; Raoul C Hennekam; Roland P Kuiper; Saskia M Maas; Eamonn R Maher; Kim E Nichols; Sharon E Plon; Christopher C Porter; Surya Rednam; Kris Ann P Schultz; Lisa J States; Gail E Tomlinson; Kristin Zelley; Todd E Druley
Journal:  Clin Cancer Res       Date:  2017-07-01       Impact factor: 12.531

7.  Mutations in CD96, a member of the immunoglobulin superfamily, cause a form of the C (Opitz trigonocephaly) syndrome.

Authors:  Tadashi Kaname; Kumiko Yanagi; Yasutsugu Chinen; Yoshio Makita; Nobuhiko Okamoto; Hiroki Maehara; Ichiro Owan; Fuminori Kanaya; Yoshiaki Kubota; Yuichi Oike; Toshiyuki Yamamoto; Kenji Kurosawa; Yoshimitsu Fukushima; Axel Bohring; John M Opitz; Ko-Ichiro Yoshiura; Norio Niikawa; Kenji Naritomi
Journal:  Am J Hum Genet       Date:  2007-08-27       Impact factor: 11.025

8.  Understanding the phenotypic spectrum of ASXL-related disease: Ten cases and a review of the literature.

Authors:  Vishnu Anand Cuddapah; Holly A Dubbs; Laura Adang; Steven L Kugler; Elizabeth M McCormick; Zarazuela Zolkipli-Cunningham; Xilma R Ortiz-González; Shana McCormack; Elaine Zackai; Daniel J Licht; Marni J Falk; Eric D Marsh
Journal:  Am J Med Genet A       Date:  2021-03-10       Impact factor: 2.578

9.  Novel de novo frameshift variant in the ASXL3 gene in a child with microcephaly and global developmental delay.

Authors:  Marketa Wayhelova; Jan Oppelt; Jan Smetana; Eva Hladilkova; Hana Filkova; Eva Makaturova; Petra Nikolova; Rastislav Beharka; Renata Gaillyova; Petr Kuglik
Journal:  Mol Med Rep       Date:  2019-05-27       Impact factor: 2.952

10.  Exome sequencing reveals a novel splice site variant in HUWE1 gene in patients with suspected Say-Meyer syndrome.

Authors:  Babylakshmi Muthusamy; Thong T Nguyen; Aravind K Bandari; Salah Basheer; Lakshmi Dhevi N Selvan; Deepshikha Chandel; Jesna Manoj; Srimonta Gayen; Somasekar Seshagiri; Satish Chandra Girimaji; Akhilesh Pandey
Journal:  Eur J Med Genet       Date:  2019-02-21       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.